FTRE
Price
$5.39
Change
+$0.45 (+9.11%)
Updated
Jul 1, 02:34 PM (EDT)
Capitalization
447.27M
48 days until earnings call
JAZZ
Price
$109.44
Change
+$3.32 (+3.13%)
Updated
Jul 1, 04:59 PM (EDT)
Capitalization
6.42B
29 days until earnings call
Interact to see
Advertisement

FTRE vs JAZZ

Header iconFTRE vs JAZZ Comparison
Open Charts FTRE vs JAZZBanner chart's image
Fortrea Holdings
Price$5.39
Change+$0.45 (+9.11%)
Volume$695
Capitalization447.27M
Jazz Pharmaceuticals
Price$109.44
Change+$3.32 (+3.13%)
Volume$21.76K
Capitalization6.42B
FTRE vs JAZZ Comparison Chart in %
Loading...
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FTRE vs. JAZZ commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTRE is a Hold and JAZZ is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (FTRE: $4.94 vs. JAZZ: $106.12)
Brand notoriety: FTRE and JAZZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FTRE: 50% vs. JAZZ: 72%
Market capitalization -- FTRE: $447.27M vs. JAZZ: $6.42B
FTRE [@Biotechnology] is valued at $447.27M. JAZZ’s [@Biotechnology] market capitalization is $6.42B. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FTRE’s FA Score shows that 1 FA rating(s) are green whileJAZZ’s FA Score has 0 green FA rating(s).

  • FTRE’s FA Score: 1 green, 4 red.
  • JAZZ’s FA Score: 0 green, 5 red.
According to our system of comparison, FTRE is a better buy in the long-term than JAZZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FTRE’s TA Score shows that 3 TA indicator(s) are bullish while JAZZ’s TA Score has 3 bullish TA indicator(s).

  • FTRE’s TA Score: 3 bullish, 7 bearish.
  • JAZZ’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, JAZZ is a better buy in the short-term than FTRE.

Price Growth

FTRE (@Biotechnology) experienced а -3.14% price change this week, while JAZZ (@Biotechnology) price change was -0.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.01%. For the same industry, the average monthly price growth was +33.00%, and the average quarterly price growth was +4.34%.

Reported Earning Dates

FTRE is expected to report earnings on Aug 18, 2025.

JAZZ is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (-0.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JAZZ($6.42B) has a higher market cap than FTRE($447M). JAZZ YTD gains are higher at: -13.829 vs. FTRE (-73.512). JAZZ has higher annual earnings (EBITDA): 1.25B vs. FTRE (-552.6M). JAZZ has more cash in the bank: 2.57B vs. FTRE (102M). FTRE has less debt than JAZZ: FTRE (1.29B) vs JAZZ (5.42B). JAZZ has higher revenues than FTRE: JAZZ (4.07B) vs FTRE (2.69B).
FTREJAZZFTRE / JAZZ
Capitalization447M6.42B7%
EBITDA-552.6M1.25B-44%
Gain YTD-73.512-13.829532%
P/E RatioN/A14.41-
Revenue2.69B4.07B66%
Total Cash102M2.57B4%
Total Debt1.29B5.42B24%
FUNDAMENTALS RATINGS
JAZZ: Fundamental Ratings
JAZZ
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
60
PRICE GROWTH RATING
1..100
77
P/E GROWTH RATING
1..100
90
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FTREJAZZ
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
63%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
64%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
59%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
55%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
61%
Advances
ODDS (%)
Bullish Trend 20 days ago
70%
Bullish Trend 22 days ago
61%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
56%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
56%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RPV93.760.51
+0.55%
Invesco S&P 500® Pure Value ETF
SDY135.730.47
+0.35%
SPDR® S&P Dividend ETF
DYLD22.630.07
+0.31%
LeaderShares® Dynamic Yield ETF
GMAR38.950.04
+0.11%
FT Vest U.S. Eq Mod Buffr ETF - Mar
XTN80.50-0.31
-0.38%
SPDR® S&P Transportation ETF

FTRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FTRE has been loosely correlated with SYRE. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if FTRE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FTRE
1D Price
Change %
FTRE100%
-0.80%
SYRE - FTRE
41%
Loosely correlated
-1.64%
TECH - FTRE
40%
Loosely correlated
-0.75%
DNLI - FTRE
40%
Loosely correlated
-0.78%
BHVN - FTRE
40%
Loosely correlated
+0.14%
OCUL - FTRE
39%
Loosely correlated
+0.65%
More